Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Bjursten
Observed names:
Bjursten, Sara,
S. Bjursten
Institutions:
Sahlgrenska University Hospital,
University of Gothenburg
Observed institutions:
Sahlgrenska University Hospital,
Centre Hospitalier Universitaire Vaudois,
Region Västra Götaland,
Pfizer (Japan),
Ludwig-Maximilians-Universität München,
University of Gothenburg,
University of Lausanne
show all 7
ORCID:
0000-0001-6730-0188
Observed ORCID:
0000-0001-6730-0188
OpenAlex ID:
A5091306292
Real-world data on PD-1 inhibitor therapy in metastatic melanoma
2019
·
Anna Arheden
, Joanna Skalenius
, et al.
·
Acta Oncologica
·
43
Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases
2018
·
Henrik Jespersen
, Sara Bjursten
, et al.
·
The Lancet Oncology
·
34
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis
2021
·
Sara Bjursten
, Ankur Pandita
, et al.
·
Journal for ImmunoTherapy of Cancer
·
33
PDF
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation
2024
·
Sara Bjursten
, Zhiyuan Zhao
, et al.
·
EBioMedicine
·
30
PDF
Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma
2021
·
Ankur Pandita
, Matias Ekstrand
, et al.
·
American Journal Of Pathology
·
28
PDF
Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint‐Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor–Induced Inflammatory Arthritis
2022
·
Mariele Gatto
, Sara Bjursten
, et al.
·
Arthritis & Rheumatology
·
25
PDF
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab
2025
·
Hifaa Al Remawi
, Maria Lindén
, et al.
·
OncoImmunology
·
10
PDF
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma
2019
·
Sara Bjursten
, Christoffer Vannas
, et al.
·
Case Reports in Oncology
·
8
Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment
2023
·
Helga B. Brynjarsdottir
, Sara Bjursten
, et al.
·
The Journal of Rheumatology
·
5
PDF
Time of day of neoadjuvant immune checkpoint inhibitor administration is associated with survival but not pathological response in resectable stage III–IV melanoma: A retrospective cohort study
2026
·
Axel Nelson
, Safa Alghaib
, et al.
·
European Journal of Cancer
·
2
Quantum Key Distribution: Security Analysis of BB84 and E91 Under Realistic Attack Models
2026
·
Bjursten, Sara
·
DiVA (Digitala Vetenskapliga Arkivet)
·
2
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure
2025
·
Maria Lindén
, Hifaa Al Remawi
, et al.
·
Immunotherapy Advances
·
2
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
2025
·
Anna Fager
, Matilda Samuelsson
, et al.
·
BJC Reports
·
2
PDF
Checkpoint inhibitor-induced adverse events in the CNS - T-cell characteristics and biomarkers
2023
·
Bjursten, Sara
·
Gothenburg University Publications Electronic Archive (Gothenburg University)
·
1
1261 Increased concentrations of S100B and neurofilament light chain in serum indicate checkpoint inhibitor-induced CNS inflammation
2022
·
Sara Bjursten
, Ankur Pandita
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Dynamic ctDNA evaluation of a patient with BRAFV600E metastatic melanoma demonstrates the utility of ctDNA for disease monitoring and tumor clonality analysis
2020
·
C. Vannas
, S. Bjursten
, et al.
·
Acta Oncologica
·
1
959 Adipose tissue regeneration after checkpoint inhibitor-induced generalized lipodystrophy demonstrates reversibility of autoimmune fat loss
2026
·
Hifaa Al Remawi
, Sara Bjursten
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
979 Checkpoint inhibitor-induced sarcoidosis is characterized by expansion of antigen-presenting, IFITM2 + non-classical monocytes
2026
·
Ankur Pandita
, Timothy Sundell
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
977 An ICOS–IFN-γ T-cell signature links CNS immune-related adverse events and immune-mediated hepatitis following dual CTLA-4/PD-1 blockade
2026
·
Sara Bjursten
, Maria Lindén
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Op0186 Changes in Circulating B Cell Levels and Immunophenotype Are Associated With Development of Arthritis Following Treatment With Checkpoint Inhibitors
2021
·
M. Gatto
, S. Bjursten
, et al.
·
Annals of the Rheumatic Diseases
PDF
Ansprechen auf BRAF/MEK-Inhibition bei einem Melanom mit BRAF-Mutation A598_T599insV
2020
·
Sara Bjursten
, Christoffer Vannas
, et al.
·
Kompass Onkologie
Real-world data on PD-1 inhibitor therapy in metastatic melanoma
2019
·
Arheden, Anna
, Skalenius, Joanna
, et al.
·
Figshare
Show more works
View as search
Works count:
23
Citation count:
227
H-index:
8
I10-index:
7
Year
Topic
Type